Two Gain-of-Function Variants of ROCK2 and ROCK3 of the Cytokinin Receptors AHK2 and AHK3

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent describes gain-of-function variants, called rock2 and rock3, in the cytokinin receptor proteins AHK2 and AHK3. It covers isolated nucleic acids encoding these protein variants and methods for generating transgenic organisms, especially plants, that include at least one of these cytokinin receptor variants. These modifications can enhance or alter cytokinin signaling in the organisms.

Use CasesContent extracted from patent full text and abstract with AI.

• Development of genetically modified crops with improved growth or yield.
• Production of plants with enhanced stress resistance, such as drought or salinity tolerance.
• Creation of research tools to study cytokinin signaling in plant biology.
• Genetic engineering of ornamental plants for desirable traits such as larger flowers or altered growth patterns.

BenefitsContent extracted from patent full text and abstract with AI.

• Enhanced plant growth and development through improved cytokinin signaling.
• Potential for increased agricultural yields and food security.
• Enabling plants to better withstand environmental stresses.
• Facilitation of advanced plant research leading to additional agricultural innovations.

Inventors & Applicants

Patent Abstract

Dos variantes de ganancia de funcion, denominadas rock2 y rock3, de las proteínas de los receptores de citoquinina AHK2 y AHK3: organismos transgénicos que comprenden al menos una de dichas variantes de ganancia de funcion del receptor de citoquinina y un método para elaborar una planta transgénica que comprende al menos una de las variantes de ganancia de funcion. Reivindicacion 1: Un ácido nucleico aislado caracterizado porque comprende una secuencia que codifica i) una secuencia de aminoácidos como SEQ ID Ns 1 o un ortologo de ésta; ii) una secuencia de aminoácidos que tiene al menos 48%, preferiblemente al menos 50%, más preferiblemente al menos 55% de identidad a lo largo de toda la secuencia SEQ ID Ns 1; o iii) una secuencia de aminoácidos que tiene al menos 50%, preferiblemente al menos 53%, más preferiblemente 55% de identidad en un segmento de 50 aminoácidos de la secuencia SEQ ID Ns 1, donde dicho segmento es SEQ ID Ns 5; donde la secuencia de aminoácidos presenta el aminoácido fenilalanina (F) en una posicion que corresponde a la posicion 552 de SEQ ID Ns 1.